The U.S. dietary supplement industry pulls in roughly $50 billion a year, supported by a regulatory framework that is, by design, much lighter than the one governing pharmaceuticals. The result is an aisle full of products with confident health claims and surprisingly thin underlying evidence. Some supplements are useful. Most are not, and the ones that aren’t are marketed as enthusiastically as the ones that are.
How DSHEA broke the rules
The 1994 Dietary Supplement Health and Education Act (DSHEA) put supplements in their own regulatory category, distinct from drugs and food. Manufacturers don’t need to prove their products work before selling them. They don’t even need to prove the bottle contains what the label says, because pre-market testing isn’t required. The FDA can act after the fact if a product is clearly dangerous, but the burden is on regulators, not the company. Independent lab tests have repeatedly found supplements that contain less of the active ingredient than advertised, more of it, or different ingredients entirely. A 2013 New York Attorney General investigation found four of five major retailers selling herbal supplements that contained little or none of the labeled herb.
The studies that get cited
Supplement marketing leans heavily on small, short-duration studies that found a positive effect. What it doesn’t mention is that most of these results never replicate, that the effect sizes are usually trivial, or that the studies were industry-funded with conflicts of interest baked in. Glucosamine for joint pain, fish oil for cardiovascular events, multivitamins for general health — these have all been the subject of well-powered randomized trials in the past 15 years, and most have come back with disappointing results. The headline study from 2002 stays on the marketing page; the 2018 meta-analysis that contradicts it does not.
The few supplements that do hold up
This isn’t a case for nihilism. Some supplements have solid evidence behind them, in specific populations. Vitamin D for documented deficiency. Folate during pregnancy. B12 for vegans and many older adults. Iron for diagnosed iron-deficiency anemia. Creatine for resistance training, with one of the cleanest evidence bases of any supplement on the market. Magnesium for certain types of migraine, with reasonable but not airtight data. Notice the pattern: these supplements address a specific deficiency or have been tested in well-defined contexts, and they’re cheap. They’re not the products with the slickest packaging.
How to read the aisle
A few practical heuristics save a lot of money. Be skeptical of any product making multiple unrelated health claims (energy, immunity, sleep, focus all in one bottle). Look for third-party testing seals — USP, NSF, ConsumerLab — which at least confirm the bottle contains what it claims. Ignore proprietary blends, which conceal dosages. Cross-reference any specific health claim with Examine.com or Cochrane reviews. If a product’s main support is testimonials and a single 60-person study, treat it as entertainment, not medicine.
The takeaway
The supplement industry is a marketing business that happens to sell pills. A small subset of products is genuinely useful, particularly for people with documented deficiencies. The rest is a tax on hope. Spending less on supplements and more on sleep, exercise, and vegetables is, for almost everyone, a better return on health.
Leave a Reply